Pig cells implanted into human brain as Parkinson’s treatment

News

Author: Parkinson's Life editorsPublished: 21 June 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

A new treatment, which involves the implantation of pig cells into a human brain, is being tested as a potential treatment for Parkinson’s.

The therapy, called NTCELL, has been developed by New Zealand-based biotechnology company Living Cell Technologies, and produces factors that promote central nerve system growth and repair nerve degeneration.

Although still in the early stages of testing, the results have been promising with those being treated showing an improvement over an 18-month period.

Roger Barker, professor of Clinical Neurosciences at the University of Cambridge, said: “The strategy is a good idea. The question is how competitive that will be compared with other cell therapies.”

The treatment could be available as early as 2018.

Go Back

Share this story

Comments


Related articles


survey

Advances

New Parkinson’s survey to campaign for better quality of life

Have your say on living with Parkinson’s

READ MORE

Global update

Indian Ocean Row 2018: the story so far

An update on the four men rowing 3,600 miles for Parkinson’s

READ MORE
Rosemary maguire

Perspectives

Leading campaigners pay tribute to pioneering Parkinson’s nurse

Praising the “huge contribution” of late Parkinson’s specialist nurse

READ MORE